Closing Bell: Markets End Day In Negative; Sensex At 65,512.10, Nifty Below 19,600

Closing Bell: Markets End Day In Negative; Sensex At 65,512.10, Nifty Below 19,600

From the Sensex pack, Bajaj Finance, LT, Bajaj Finserv, Titan, and SBI were among the top gainers. Maruti, NTPC, Sun Pharma, Tata Motors, ICICI Bank, and HDFC Bank were among the laggards.

FPJ Web DeskUpdated: Tuesday, October 03, 2023, 03:39 PM IST
article-image
Closing Bell: Markets End Day In Negative; Sensex At 65,512.10, Nifty Below 19,600 | File photo

Today, the benchmark indices ended on a negative note with Nifty below 19,600.

The 30-share BSE Sensex shed 316.31 points or 0.48 percent to end the day at 65,512.10. The NSE Nifty went down by 116.15 points or 0.59 percent to end the day at 19,522.15.

The Nifty Bank fell by 197.05 points or 0.44 percent to 44,387.50.

From the Sensex pack, Bajaj Finance, LT, Bajaj Finserv, Titan, and SBI were among the top gainers. Maruti, NTPC, Sun Pharma, Tata Motors, ICICI Bank, and HDFC Bank were among the laggards.

From the Nifty 50 pack, Bajaj Finance, LT, Bajaj Finserv, Titan, and SBI were among the major gainers, whereas ONGC, Eicher Motors, Maruti, Hindalco, Dr Reddy's Lab were among the losers.

Markets on Friday morning

The markets fell on Tuesday with Sensex at 65,622.27, down by 206.14 points and Nifty was at 19,543.15 with a loss of 95.15 points.

RECENT STORIES

Canara Bank Net Profit Climbs To ₹5,155 Crore In Q3 FY26, Revenue Rises 10% YoY To ₹39,881 Crore
Canara Bank Net Profit Climbs To ₹5,155 Crore In Q3 FY26, Revenue Rises 10% YoY To ₹39,881 Crore
CBI Raids Multiple Locations In Kolkata Over ₹1,000 Crore Bank Fraud By Finance Company Promoters
CBI Raids Multiple Locations In Kolkata Over ₹1,000 Crore Bank Fraud By Finance Company Promoters
India’s Growth Potential Raised To 7%, Economic Survey 2025-26
India’s Growth Potential Raised To 7%, Economic Survey 2025-26
Budget Session Marks New Momentum For Viksit Bharat 2047, India-EU FTA Signals Bright Future For...
Budget Session Marks New Momentum For Viksit Bharat 2047, India-EU FTA Signals Bright Future For...
Gland Pharma Shares Surge Over 9%, Q3 FY26 Profit Rises 28% To ₹261 Crore
Gland Pharma Shares Surge Over 9%, Q3 FY26 Profit Rises 28% To ₹261 Crore